封面
市場調查報告書
商品編碼
1954584

全球經直腸超音波市場:市場規模、佔有率、成長率、產業分析、依類型、應用和地區劃分的分析及預測(2026-2034年)

Transrectal Ultrasound Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034

出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 163 Pages | 商品交期: 請詢問到貨日

價格

經直腸超音波市場成長驅動因素

2025年全球經直腸超音波市場規模為 2.7111億美元,預計將從2026年的2.8797億美元成長至2034年的4.8964億美元,預測期內(2026-2034年)年複合成長率(CAGR)為 6.90%。北美地區將在2025年以 29.10%的市場佔有率引領市場,這主要歸功於該地區前列腺癌的高發病率、先進的醫療基礎設施以及有利的醫保償付政策。

經直腸超音波檢查(TRUS),也稱為直腸超音波或攝護腺超音波,是一種微創影像技術,主要用於診斷攝護腺癌、良性攝護腺增生(BPH)和攝護腺炎。此檢查需要將探頭插入直腸,並利用聲波產生前列腺的詳細影像。 TRUS 在前列腺癌篩檢、活檢引導和影像引導治療中發揮著非常重要的作用。

新冠疫情的影響

2020年,由於泌尿科手術減少和擇期手術推遲,新冠疫情對市場造成了重大影響。由於許多醫療系統優先治療新冠患者,前列腺癌篩檢和診斷影像被推遲。然而,從2020年第四季到2021年第一季,擇期手術逐漸恢復,市場需求趨於穩定。從2022年起,預計市場將穩定復甦,並持續成長至2034年。

市場概覽及關鍵指標

  • 市場規模(2025年):2.7111億美元
  • 市場規模(2026年):2.8797億美元
  • 市場規模預測(2034年):4.8964億美元
  • 年複合成長率(2026-2034年):6.90%
  • 北美市場佔有率(2025年):29.10%

市場趨勢

先進影像與人工智慧整合系統的應用

領先企業加速推出具有增強成像功能的創新超音波平台。磁振造影-超音波融合活檢、高解析度微超音波和即時彈性成像等技術改變前列腺癌的診斷方式。

例如,ExactVu 微超音波平台採用 29MHz 的頻率,可實現前列腺組織的精細可視化。2023年 4月,EDAP TMS 的ExactVu 微超音波活檢系統在日本獲得銷售許可。此外,基於人工智慧的影像分析工具的開發也進行中,以提高診斷準確性。2023年發表的研究強調了人工智慧在經直腸超音波(TRUS)影像輔助前列腺癌鑑別診斷、改善活檢引導和提升診斷效果方面日益重要的作用。 市場成長因素

攝護腺癌發生率呈上升趨勢

攝護腺癌是全球男性最常見的癌症之一。根據世界癌症研究基金會(WCRF International)的資料,攝護腺癌是男性第二大常見癌症,2020年全球報告的新病例超過 140萬例。過去20年發病率的上升顯著增加了對早期檢測和診斷影像技術(例如經直腸超音波檢查(TRUS))的需求。

強而有力的償付政策和政府主導的措施

支持性的償付框架和宣傳活動促進早期診斷。諸如前列腺癌篩檢資助計畫和宣傳活動等措施推動先進診斷技術的應用。專注於超音波檢查償付策略的會議和政策舉措進一步鞏固了市場格局。

限制因子

儘管技術不斷進步,市場仍面臨產品召回和監管等挑戰。例如,近年來某些超音波系統的召回影響了其普及率。此外,訓練有素的技術人員和泌尿科醫生短缺,尤其是在已開發國家,可能會限制檢查能力。嚴格的監管要求也增加了製造商的合規成本。

市場區隔分析

依產品劃分

市場依產品分為系統與感測器兩大類。

  • 在持續的產品發布和監管批准的支持下,系統細分市場預計到2026年將佔據主導地位,市場佔有率達到 88.30%。 由於感測器在前列腺癌篩檢和診斷中的廣泛應用,預計感測器細分市場將實現最高的年複合成長率。

依類型

市場分為推車式/手推車式系統和便攜式系統。

  • 到2026年,推車式/手推車式系統將佔據92.72%的市場佔有率,這主要得益於醫院和門診手術中心(ASC)的高普及率。
  • 由於技術進步和對微創即時成像解決方案需求的不斷成長,便攜式系統預計將以最高的年複合成長率成長。

依應用

市場依應用分為診斷與影像導引治療。

  • 到2026年,診斷領域將佔據86.22%的市場佔有率,這主要得益於攝護腺癌發生率的上升。 由於融合活檢和聚焦消融手術的日益普及,影像導引治療領域預計將保持穩定成長。

依最終使用者劃分

市場細分為醫院和門診手術中心(ASC)、診斷實驗室和其他機構。

  • 到2026年,醫院和門診手術中心細分市場將佔據主導地位,市場佔有率達 78.03%,因為大多數前列腺相關手術都在醫院進行。
  • 由於對償付支援和專業影像診斷服務的需求增加,診斷實驗室細分市場預計將實現顯著成長。

區域洞察

北美

北美市場規模到2025年達到 7,889萬美元,憑藉其較高的前列腺癌發病率和完善的醫療保健基礎設施,北美將繼續保持其主要市場地位。提高公眾意識和加強篩檢推廣工作推動進一步成長。

歐洲

在歐洲,預計年複合成長率將顯著提高,這得益於政府為促進前列腺癌早期檢測而採取的舉措以及先進活檢解決方案的監管審批。

亞太地區

由於醫療基礎設施的不斷完善、老舊超音波系統的升級以及中國、印度和日本等國家醫療支出的增加,亞太地區預計將實現強勁成長。

拉丁美洲、中東和非洲

由於認知度較低和醫療支出不足,這些地區的年複合成長率預計相對較低,但診斷的可及性預計將逐步提高。

主要公司

市場上主要的公司包括:

  • GE Healthcare (BK Medical Holding Company, Inc.)
  • KOELIS
  • Exact Imaging
  • FUJIFILM Corporation
  • Koninklijke Philips N.V.
  • Telemed Medical Systems
  • Strata Imaging
  • HALO Medical Technologies

這些公司致力於收購、產品創新和獲得監管部門批准,以增強其競爭力。

產業主要動態

  • 2023年7月:Teleflex 收購 Pallet Life Sciences,以擴展其介入泌尿外科領域的產品線。
  • 2021年12月:GE醫療收購 BK Medical Holding Company, Inc.。
  • 2021年4月:KOELIS 啟動了 VIOLETTE 臨床試驗,用於研究 3D 融合影像導引的局部消融技術。

目錄

第1章 引言

第2章 執行摘要

第3章 市場動態

  • 市場驅動因素
  • 市場限制因素
  • 市場機會
  • 市場趨勢

第4章 主要發現

  • 主要國家和地區前列腺癌和良性前列腺增生(BPH)的盛行率(2025年)
  • 經直腸超音波市場的技術進步
  • 市場主要企業的差異化策略
  • 主要產業趨勢(併購、合作)
  • 影響COVID-19 對市場的影響

第5章 全球經直腸超音波市場分析:洞察與預測(2021-2034)

  • 市場分析、洞察與預測:依產品分類
    • 系統
    • 換能器
  • 市場分析、洞察與預測:依類型
    • 推車/手推車底座
    • 便攜式
  • 市場分析、洞察與預測:依應用
    • 診斷
      • 攝護腺癌
      • 良性攝護腺增生(BPH)
      • 其他
    • 影像導引治療
  • 市場分析、洞察與預測:依最終用戶
    • 醫院及門診手術中心
    • 診斷實驗室
    • 其他
  • 市場分析、洞察與預測:依地區劃分
    • 北美
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲

第6章 北美經直腸超音波市場分析:洞察與預測(2021-2034)

  • 依國家劃分
    • 美國
    • 加拿大

第7章 歐洲經直腸超音波市場分析:洞察與預測(2021-2034)

  • 依國家劃分
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 斯堪的納維亞
    • 其他歐洲國家

第8章 亞太經直腸超音波市場分析:洞察與預測(2021-2034)

  • 依國家劃分
    • 日本
    • 澳洲
    • 中國
    • 印度
    • 東南亞
    • 其他亞太地區

第9章 拉丁美洲經直腸超音波市場分析:洞察與預測(2021-2034)

  • 依國家劃分
    • 巴西
    • 墨西哥
    • 其他拉丁美洲國家美國

第10章 中東與非洲經直腸超音波市場分析:洞察與預測(2021年~2034年)

  • 依國家劃分
    • GCC
    • 南非
    • 中東和非洲

第11章 競爭分析

  • 全球市佔率分析(2025)
  • 公司簡介
    • KOELIS
    • GE Healthcare(BK Medical Holding Company, Inc.)
    • Exact Imaging
    • Telemed Medical Systems
    • FUJIFILM Corporation
    • Strata Imaging
    • HALO Medical Technologies
    • GEOTEK
    • Koninklijke Philips N.V.
Product Code: FBI100137

Growth Factors of transrectal ultrasound Market

The global transrectal ultrasound market size was valued at USD 271.11 million in 2025 and is projected to grow from USD 287.97 million in 2026 to USD 489.64 million by 2034, registering a CAGR of 6.90% during the forecast period (2026-2034). North America dominated the market with a 29.10% share in 2025, driven by a high prevalence of prostate cancer, advanced healthcare infrastructure, and favorable reimbursement policies.

Transrectal ultrasound (TRUS), also known as endorectal ultrasound or prostate sonogram, is a minimally invasive imaging technique used primarily for diagnosing prostate-related conditions such as prostate cancer, benign prostatic hyperplasia (BPH), and prostatitis. The procedure involves inserting a probe into the rectum to produce detailed images of the prostate using sound waves. TRUS plays a crucial role in prostate cancer screening, biopsy guidance, and image-guided therapies.

COVID-19 IMPACT

The COVID-19 pandemic significantly affected the market in 2020 due to a decline in urological procedures and postponement of elective surgeries. Several healthcare systems prioritized COVID-19 patients, leading to delays in prostate cancer screenings and diagnostic imaging. However, between Q4 2020 and Q1 2021, elective procedures gradually resumed, stabilizing market demand. From 2022 onwards, the market witnessed steady recovery, and growth is expected to continue through 2034.

MARKET OVERVIEW & KEY METRICS

  • 2025 Market Size: USD 271.11 million
  • 2026 Market Size: USD 287.97 million
  • 2034 Forecast Market Size: USD 489.64 million
  • CAGR (2026-2034): 6.90%
  • North America Market Share (2025): 29.10%

MARKET TRENDS

Launch of Advanced Imaging and AI-Integrated Systems

Leading companies are increasingly launching innovative ultrasound platforms with enhanced imaging capabilities. Technologies such as MRI-US fusion biopsy, high-resolution micro-ultrasound, and real-time elastography are transforming prostate cancer diagnostics.

For example, the ExactVu micro-ultrasound platform uses a 29 MHz frequency to provide detailed visualization of prostate tissues. In April 2023, EDAP TMS received regulatory approval in Japan to commercialize its ExactVu micro-ultrasound biopsy system. Additionally, AI-based imaging tools are being developed to improve diagnostic precision. Studies published in 2023 highlight the growing role of artificial intelligence in differentiating prostate cancer using TRUS images, improving biopsy guidance and diagnostic outcomes.

MARKET GROWTH FACTORS

Increasing Prevalence of Prostate Cancer

Prostate cancer is one of the most common cancers among men globally. According to the World Cancer Research Fund International, prostate cancer is the second most frequently occurring cancer in men, with over 1.4 million new cases reported worldwide in 2020. Rising incidence rates over the past two decades have significantly increased the demand for early detection and diagnostic imaging technologies such as TRUS.

Strong Reimbursement Policies and Government Initiatives

Supportive reimbursement frameworks and awareness programs are encouraging early diagnosis. Initiatives such as funding programs for prostate cancer research and screening awareness campaigns are promoting the adoption of advanced diagnostic technologies. Conferences and policy initiatives focusing on ultrasound reimbursement strategies have further strengthened the market landscape.

RESTRAINING FACTORS

Despite technological advancements, the market faces challenges including product recalls and regulatory scrutiny. For instance, recalls of certain ultrasound systems in previous years have affected adoption rates. Additionally, a shortage of trained technicians and urologists, particularly in developed countries, may limit procedural capacity. Stringent regulatory requirements also increase compliance costs for manufacturers.

MARKET SEGMENTATION ANALYSIS

By Product

The market is segmented into systems and transducers.

  • The systems segment dominated with an 88.30% market share in 2026, supported by continuous product launches and regulatory approvals.
  • The transducers segment is projected to record the highest CAGR due to their widespread use in prostate cancer screening and diagnosis.

By Type

The market is divided into cart/trolley-based and portable systems.

  • The cart/trolley-based segment held 92.72% share in 2026, owing to high adoption in hospitals and ambulatory surgical centers (ASCs).
  • The portable segment is expected to grow at the highest CAGR due to technological advancements and increasing demand for minimally invasive and point-of-care imaging solutions.

By Application

The market is segmented into diagnostic and image-guided treatment.

  • The diagnostic segment accounted for 86.22% share in 2026, driven by the rising incidence of prostate cancer.
  • The image-guided treatment segment is expected to grow steadily due to increasing adoption of fusion biopsy and focal ablation procedures.

By End-User

The market is categorized into hospitals & ASCs, diagnostic laboratories, and others.

  • The hospitals & ASCs segment led with 78.03% share in 2026, as most prostate procedures are conducted in hospital settings.
  • The diagnostic laboratories segment is anticipated to witness significant growth owing to reimbursement support and growing demand for specialized imaging services.

REGIONAL INSIGHTS

North America

North America generated USD 78.89 million in 2025 and remained the leading region due to high prostate cancer prevalence and strong healthcare infrastructure. Increased awareness and screening initiatives are further driving growth.

Europe

Europe is projected to record a significant CAGR, supported by government initiatives promoting early prostate cancer detection and regulatory approvals for advanced biopsy solutions.

Asia Pacific

Asia Pacific is expected to witness strong growth due to expanding healthcare infrastructure, replacement of outdated ultrasound systems, and increasing healthcare expenditure in countries such as China, India, and Japan.

Latin America & Middle East & Africa

These regions are anticipated to grow at a comparatively lower CAGR due to limited awareness and lower healthcare spending, though gradual improvements in diagnostic access are expected.

KEY INDUSTRY PLAYERS

Major companies operating in the market include:

  • GE Healthcare (BK Medical Holding Company, Inc.)
  • KOELIS
  • Exact Imaging
  • FUJIFILM Corporation
  • Koninklijke Philips N.V.
  • Telemed Medical Systems
  • Strata Imaging
  • HALO Medical Technologies

These players focus on acquisitions, product innovation, and regulatory approvals to strengthen their competitive position.

KEY INDUSTRY DEVELOPMENTS

  • July 2023: Teleflex Incorporated acquired Palette Life Sciences AB to expand its interventional urology portfolio.
  • December 2021: GE Healthcare acquired BK Medical Holding Company, Inc.
  • April 2021: KOELIS initiated the VIOLETTE clinical trial for 3D fusion imaging-guided focal ablation.
  • May 2020: EDAP TMS signed a global distribution agreement with Exact Imaging.

CONCLUSION

The global transrectal ultrasound market is projected to grow from USD 271.11 million in 2025 to USD 489.64 million by 2034, expanding at a CAGR of 6.90%. The market is expected to reach USD 287.97 million in 2026, supported by increasing prostate cancer prevalence, advancements in AI-integrated imaging systems, and favorable reimbursement policies. Although challenges such as regulatory scrutiny and technician shortages persist, continuous technological innovation and growing awareness of early cancer detection are expected to sustain long-term market growth through 2034.

Segmentation By Product

  • Systems
  • Transducers

By Type

  • Cart/ Trolley-based
  • Portable

By Application

  • Diagnostic
    • Prostate Cancer
    • BPH (Benign Prostatic Hyperplasia)
    • Others
  • Image-guided Treatment

By End-user

  • Hospitals & ASCs
  • Diagnostic Laboratories
  • Others

By Region

  • North America (By Product, Type, Application, End-user, and Country)
    • U.S.
    • Canada
  • Europe (By Product, Type, Application, End-user, and Country/Sub-Region)
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Product, Type, Application, End-user, and Country/Sub-Region)
    • China
    • India
    • Japan
    • Australia
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America (By Product, Type, Application, End-user, and Country/Sub-Region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Product, Type, Application, End-user, and Country/Sub-Region)
    • GCC
    • South Africa
  • Rest of Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Prevalence of Prostate Cancer and Benign Prostatic Hyperplasia (BPH), Key Countries/ Region, 2025
  • 4.2. Technological Advancements in Transrectal Ultrasound Market
  • 4.3. Key Differentiating Strategies of Top Players Operating in the Market
  • 4.4. Key Industry Developments (Merges, Acquisitions and Partnerships)
  • 4.5. Impact of COVID-19 on the Market

5. Global Transrectal Ultrasound Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Product
    • 5.1.1. Systems
    • 5.1.2. Transducers
  • 5.2. Market Analysis, Insights and Forecast - By Type
    • 5.2.1. Cart/ Trolley-based
    • 5.2.2. Portable
  • 5.3. Market Analysis, Insights and Forecast - By Application
    • 5.3.1. Diagnostic
      • 5.3.1.1. Prostate Cancer
      • 5.3.1.2. BPH (Benign Prostatic Hyperplasia)
      • 5.3.1.3. Others
    • 5.3.2. Image-guided Treatment
  • 5.4. Market Analysis, Insights and Forecast - By End-user
    • 5.4.1. Hospitals & ASCs
    • 5.4.2. Diagnostic Laboratories
    • 5.4.3. Others
  • 5.5. Market Analysis, Insights and Forecast - By Region
    • 5.5.1. North America
    • 5.5.2. Europe
    • 5.5.3. Asia Pacific
    • 5.5.4. Latin America
    • 5.5.5. Middle East & Africa

6. North America Transrectal Ultrasound Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Product
    • 6.1.1. Systems
    • 6.1.2. Transducers
  • 6.2. Market Analysis, Insights and Forecast - By Type
    • 6.2.1. Cart/ Trolley-based
    • 6.2.2. Portable
  • 6.3. Market Analysis, Insights and Forecast - By Application
    • 6.3.1. Diagnostic
      • 6.3.1.1. Prostate Cancer
      • 6.3.1.2. BPH (Benign Prostatic Hyperplasia)
      • 6.3.1.3. Others
    • 6.3.2. Image-guided Treatment
  • 6.4. Market Analysis, Insights and Forecast - By End-user
    • 6.4.1. Hospitals & ASCs
    • 6.4.2. Diagnostic Laboratories
    • 6.4.3. Others
  • 6.5. Market Analysis, Insights and Forecast - By Country
    • 6.5.1. U.S.
    • 6.5.2. Canada

7. Europe Transrectal Ultrasound Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Product
    • 7.1.1. Systems
    • 7.1.2. Transducers
  • 7.2. Market Analysis, Insights and Forecast - By Type
    • 7.2.1. Cart/ Trolley-based
    • 7.2.2. Portable
  • 7.3. Market Analysis, Insights and Forecast - By Application
    • 7.3.1. Diagnostic
      • 7.3.1.1. Prostate Cancer
      • 7.3.1.2. BPH (Benign Prostatic Hyperplasia)
      • 7.3.1.3. Others
    • 7.3.2. Image-guided Treatment
  • 7.4. Market Analysis, Insights and Forecast - By End-user
    • 7.4.1. Hospitals & ASCs
    • 7.4.2. Diagnostic Laboratories
    • 7.4.3. Others
  • 7.5. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 7.5.1. U.K.
    • 7.5.2. Germany
    • 7.5.3. France
    • 7.5.4. Spain
    • 7.5.5. Italy
    • 7.5.6. Scandinavia
    • 7.5.7. Rest of Europe

8. Asia Pacific Transrectal Ultrasound Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Product
    • 8.1.1. Systems
    • 8.1.2. Transducers
  • 8.2. Market Analysis, Insights and Forecast - By Type
    • 8.2.1. Cart/ Trolley-based
    • 8.2.2. Portable
  • 8.3. Market Analysis, Insights and Forecast - By Application
    • 8.3.1. Diagnostic
      • 8.3.1.1. Prostate Cancer
      • 8.3.1.2. BPH (Benign Prostatic Hyperplasia)
      • 8.3.1.3. Others
    • 8.3.2. Image-guided Treatment
  • 8.4. Market Analysis, Insights and Forecast - By End-user
    • 8.4.1. Hospitals & ASCs
    • 8.4.2. Diagnostic Laboratories
    • 8.4.3. Others
  • 8.5. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 8.5.1. Japan
    • 8.5.2. Australia
    • 8.5.3. China
    • 8.5.4. India
    • 8.5.5. Southeast Asia
    • 8.5.6. Rest of Asia Pacific

9. Latin America Transrectal Ultrasound Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Product
    • 9.1.1. Systems
    • 9.1.2. Transducers
  • 9.2. Market Analysis, Insights and Forecast - By Type
    • 9.2.1. Cart/ Trolley-based
    • 9.2.2. Portable
  • 9.3. Market Analysis, Insights and Forecast - By Application
    • 9.3.1. Diagnostic
      • 9.3.1.1. Prostate Cancer
      • 9.3.1.2. BPH (Benign Prostatic Hyperplasia)
      • 9.3.1.3. Others
    • 9.3.2. Image-guided Treatment
  • 9.4. Market Analysis, Insights and Forecast - By End-user
    • 9.4.1. Hospitals & ASCs
    • 9.4.2. Diagnostic Laboratories
    • 9.4.3. Others
  • 9.5. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 9.5.1. Brazil
    • 9.5.2. Mexico
    • 9.5.3. Rest of Latin America

10. Middle East & Africa Transrectal Ultrasound Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Product
    • 10.1.1. Systems
    • 10.1.2. Transducers
  • 10.2. Market Analysis, Insights and Forecast - By Type
    • 10.2.1. Cart/ Trolley-based
    • 10.2.2. Portable
  • 10.3. Market Analysis, Insights and Forecast - By Application
    • 10.3.1. Diagnostic
      • 10.3.1.1. Prostate Cancer
      • 10.3.1.2. BPH (Benign Prostatic Hyperplasia)
      • 10.3.1.3. Others
    • 10.3.2. Image-guided Treatment
  • 10.4. Market Analysis, Insights and Forecast - By End-user
    • 10.4.1. Hospitals & ASCs
    • 10.4.2. Diagnostic Laboratories
    • 10.4.3. Others
  • 10.5. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 10.5.1. GCC
    • 10.5.2. South Africa
    • 10.5.3. Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles
    • 11.2.1. KOELIS
      • 11.2.1.1. Overview
      • 11.2.1.2. Products
      • 11.2.1.3. SWOT
      • 11.2.1.4. Recent Developments
      • 11.2.1.5. Strategies
      • 11.2.1.6. Financials (based on availability)
    • 11.2.2. GE Healthcare (BK Medical Holding Company, Inc.)
      • 11.2.2.1. Overview
      • 11.2.2.2. Products
      • 11.2.2.3. SWOT
      • 11.2.2.4. Recent Developments
      • 11.2.2.5. Strategies
      • 11.2.2.6. Financials (based on availability)
    • 11.2.3. Exact Imaging
      • 11.2.3.1. Overview
      • 11.2.3.2. Products
      • 11.2.3.3. SWOT
      • 11.2.3.4. Recent Developments
      • 11.2.3.5. Strategies
      • 11.2.3.6. Financials (based on availability)
    • 11.2.4. Telemed Medical Systems
      • 11.2.4.1. Overview
      • 11.2.4.2. Products
      • 11.2.4.3. SWOT
      • 11.2.4.4. Recent Developments
      • 11.2.4.5. Strategies
      • 11.2.4.6. Financials (based on availability)
    • 11.2.5. FUJIFILM Corporation
      • 11.2.5.1. Overview
      • 11.2.5.2. Products
      • 11.2.5.3. SWOT
      • 11.2.5.4. Recent Developments
      • 11.2.5.5. Strategies
      • 11.2.5.6. Financials (based on availability)
    • 11.2.6. Strata Imaging
      • 11.2.6.1. Overview
      • 11.2.6.2. Products
      • 11.2.6.3. SWOT
      • 11.2.6.4. Recent Developments
      • 11.2.6.5. Strategies
      • 11.2.6.6. Financials (based on availability)
    • 11.2.7. HALO Medical Technologies
      • 11.2.7.1. Overview
      • 11.2.7.2. Products
      • 11.2.7.3. SWOT
      • 11.2.7.4. Recent Developments
      • 11.2.7.5. Strategies
      • 11.2.7.6. Financials (based on availability)
    • 11.2.8. GEOTEK
      • 11.2.8.1. Overview
      • 11.2.8.2. Products
      • 11.2.8.3. SWOT
      • 11.2.8.4. Recent Developments
      • 11.2.8.5. Strategies
      • 11.2.8.6. Financials (based on availability)
    • 11.2.9. Koninklijke Philips N.V.
      • 11.2.9.1. Overview
      • 11.2.9.2. Products
      • 11.2.9.3. SWOT
      • 11.2.9.4. Recent Developments
      • 11.2.9.5. Strategies
      • 11.2.9.6. Financials (based on availability)

List of Tables

  • Table 1: Global Transrectal Ultrasound Market Revenue (USD million) Forecast, by Product, 2021-2034
  • Table 2: Global Transrectal Ultrasound Market Revenue (USD million) Forecast, by Type, 2021-2034
  • Table 3: Global Transrectal Ultrasound Market Revenue (USD million) Forecast, by Application, 2021-2034
  • Table 4: Global Transrectal Ultrasound Market Revenue (USD million) Forecast, by Diagnostic, 2021-2034
  • Table 5: Global Transrectal Ultrasound Market Revenue (USD million) Forecast, by End-user, 2021-2034
  • Table 6: Global Transrectal Ultrasound Market Revenue (USD million) Forecast, by Region, 2021-2034
  • Table 7: North America Transrectal Ultrasound Market Revenue (USD million) Forecast, by Product, 2021-2034
  • Table 8: North America Transrectal Ultrasound Market Revenue (USD million) Forecast, by Type, 2021-2034
  • Table 9: North America Transrectal Ultrasound Market Revenue (USD million) Forecast, by Application, 2021-2034
  • Table 10: North America Transrectal Ultrasound Market Revenue (USD million) Forecast, by Diagnostic, 2021-2034
  • Table 11: North America Transrectal Ultrasound Market Revenue (USD million) Forecast, by End-user, 2021-2034
  • Table 12: North America Transrectal Ultrasound Market Revenue (USD million) Forecast, By Country/Sub-region, 2021-2034
  • Table 13: Europe Transrectal Ultrasound Market Revenue (USD million) Forecast, by Product, 2021-2034
  • Table 14: Europe Transrectal Ultrasound Market Revenue (USD million) Forecast, by Type, 2021-2034
  • Table 15: Europe Transrectal Ultrasound Market Revenue (USD million) Forecast, by Application, 2021-2034
  • Table 16: Europe Transrectal Ultrasound Market Revenue (USD million) Forecast, by Diagnostic, 2021-2034
  • Table 17: Europe Transrectal Ultrasound Market Revenue (USD million) Forecast, by End-user, 2021-2034
  • Table 18: Europe Transrectal Ultrasound Market Revenue (USD million) Forecast, By Country/Sub-region, 2021-2034
  • Table 19: Asia Pacific Transrectal Ultrasound Market Revenue (USD million) Forecast, by Product, 2021-2034
  • Table 20: Asia Pacific Transrectal Ultrasound Market Revenue (USD million) Forecast, by Type, 2021-2034
  • Table 21: Asia Pacific Transrectal Ultrasound Market Revenue (USD million) Forecast, by Application, 2021-2034
  • Table 22: Asia Pacific Transrectal Ultrasound Market Revenue (USD million) Forecast, by Diagnostic, 2021-2034
  • Table 23: Asia Pacific Transrectal Ultrasound Market Revenue (USD million) Forecast, by End-user, 2021-2034
  • Table 24: Asia Pacific Transrectal Ultrasound Market Revenue (USD million) Forecast, By Country/ Sub-region, 2021-2034
  • Table 25: Latin America Transrectal Ultrasound Market Revenue (USD million) Forecast, by Product, 2021-2034
  • Table 26: Latin America Transrectal Ultrasound Market Revenue (USD million) Forecast, by Type, 2021-2034
  • Table 27: Latin America Transrectal Ultrasound Market Revenue (USD million) Forecast, by Application, 2021-2034
  • Table 28: Latin America Transrectal Ultrasound Market Revenue (USD million) Forecast, by Diagnostic, 2021-2034
  • Table 29: Latin America Transrectal Ultrasound Market Revenue (USD million) Forecast, by End-user, 2021-2034
  • Table 30: Latin America Transrectal Ultrasound Market Revenue (USD million) Forecast, By Country/ Sub-region, 2021-2034
  • Table 31: Middle East & Africa Transrectal Ultrasound Market Revenue (USD million) Forecast, by Product, 2021-2034
  • Table 32: Middle East & Africa Transrectal Ultrasound Market Revenue (USD million) Forecast, by Type, 2021-2034
  • Table 33: Middle East & Africa Transrectal Ultrasound Market Revenue (USD million) Forecast, by Application, 2021-2034
  • Table 34: Middle East & Africa Transrectal Ultrasound Market Revenue (USD million) Forecast, by Diagnostic, 2021-2034
  • Table 35: Middle East & Africa Transrectal Ultrasound Market Revenue (USD million) Forecast, by End-user, 2021-2034
  • Table 36: Middle East & Africa Transrectal Ultrasound Market Revenue (USD million) Forecast, By Country/Sub-region, 2021-2034

List of Figures

  • Figure 1: Global Transrectal Ultrasound Market Revenue Breakdown (USD million, %) by Region, 2025 & 2034
  • Figure 2: Global Transrectal Ultrasound Market Value Share (%), by Product, 2025 & 2034
  • Figure 3: Global Transrectal Ultrasound Market Value Share (%), by Type, 2025 & 2034
  • Figure 4: Global Transrectal Ultrasound Market Value Share (%), by Application, 2025 & 2034
  • Figure 5: Global Transrectal Ultrasound Market Value Share (%), by End-user, 2025 & 2034
  • Figure 6: Global Transrectal Ultrasound Market Value (USD million), by Region, 2025 & 2034
  • Figure 7: North America Transrectal Ultrasound Market Value (USD million), by Product, 2025 & 2034
  • Figure 8: North America Transrectal Ultrasound Market Value Share (%), by Product, 2025
  • Figure 9: North America Transrectal Ultrasound Market Value (USD million), by Type, 2025 & 2034
  • Figure 10: North America Transrectal Ultrasound Market Value Share (%), by Type, 2025
  • Figure 11: North America Transrectal Ultrasound Market Value (USD million), by Application, 2025 & 2034
  • Figure 12: North America Transrectal Ultrasound Market Value Share (%), by Application, 2025
  • Figure 13: North America Transrectal Ultrasound Market Value (USD million), by End-user, 2025 & 2034
  • Figure 14: North America Transrectal Ultrasound Market Value Share (%), by End-user, 2025
  • Figure 15: North America Transrectal Ultrasound Market Value (USD million), By Country/Sub-region, 2025 & 2034
  • Figure 16: North America Transrectal Ultrasound Market Value Share (%), By Country/Sub-region, 2025
  • Figure 17: Europe Transrectal Ultrasound Market Value (USD million), by Product, 2025 & 2034
  • Figure 18: Europe Transrectal Ultrasound Market Value Share (%), by Product, 2025
  • Figure 19: Europe Transrectal Ultrasound Market Value (USD million), by Type, 2025 & 2034
  • Figure 20: Europe Transrectal Ultrasound Market Value Share (%), by Type, 2025
  • Figure 21: Europe Transrectal Ultrasound Market Value (USD million), by Application, 2025 & 2034
  • Figure 22: Europe Transrectal Ultrasound Market Value Share (%), by Application, 2025
  • Figure 23: Europe Transrectal Ultrasound Market Value (USD million), by End-user, 2025 & 2034
  • Figure 24: Europe Transrectal Ultrasound Market Value Share (%), by End-user, 2025
  • Figure 25: Europe Transrectal Ultrasound Market Value (USD million), By Country/ Sub-region, 2025 & 2034
  • Figure 26: Europe Transrectal Ultrasound Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 27: Asia Pacific Transrectal Ultrasound Market Value (USD million), by Product, 2025 & 2034
  • Figure 28: Asia Pacific Transrectal Ultrasound Market Value Share (%), by Product, 2025
  • Figure 29: Asia Pacific Transrectal Ultrasound Market Value (USD million), by Type, 2025 & 2034
  • Figure 30: Asia Pacific Transrectal Ultrasound Market Value Share (%), by Type, 2025
  • Figure 31: Asia Pacific Transrectal Ultrasound Market Value (USD million), by Application, 2025 & 2034
  • Figure 32: Asia Pacific Transrectal Ultrasound Market Value Share (%), by Application, 2025
  • Figure 33: Asia Pacific Transrectal Ultrasound Market Value (USD million), by End-user, 2025 & 2034
  • Figure 34: Asia Pacific Transrectal Ultrasound Market Value Share (%), by End-user, 2025
  • Figure 35: Asia Pacific Transrectal Ultrasound Market Value (USD million), By Country/ Sub-region, 2025 & 2034
  • Figure 36: Asia Pacific Transrectal Ultrasound Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 37: Latin America Transrectal Ultrasound Market Value (USD million), by Product, 2025 & 2034
  • Figure 38: Latin America Transrectal Ultrasound Market Value Share (%), by Product, 2025
  • Figure 39: Latin America Transrectal Ultrasound Market Value (USD million), by Type, 2025 & 2034
  • Figure 40: Latin America Transrectal Ultrasound Market Value Share (%), by Type, 2025
  • Figure 41: Latin America Transrectal Ultrasound Market Value (USD million), by Application, 2025 & 2034
  • Figure 42: Latin America Transrectal Ultrasound Market Value Share (%), by Application, 2025
  • Figure 43: Latin America Transrectal Ultrasound Market Value (USD million), by End-user, 2025 & 2034
  • Figure 44: Latin America Transrectal Ultrasound Market Value Share (%), by End-user, 2025
  • Figure 45: Latin America Transrectal Ultrasound Market Value (USD million), By Country/ Sub-region, 2025 & 2034
  • Figure 46: Latin America Transrectal Ultrasound Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 47: Middle East & Africa Transrectal Ultrasound Market Value (USD million), by Product, 2025 & 2034
  • Figure 48: Middle East & Africa Transrectal Ultrasound Market Value Share (%), by Product, 2025
  • Figure 49: Middle East & Africa Transrectal Ultrasound Market Value (USD million), by Type, 2025 & 2034
  • Figure 50: Middle East & Africa Transrectal Ultrasound Market Value Share (%), by Type, 2025
  • Figure 51: Middle East & Africa Transrectal Ultrasound Market Value (USD million), by Application, 2025 & 2034
  • Figure 52: Middle East & Africa Transrectal Ultrasound Market Value Share (%), by Application, 2025
  • Figure 53: Middle East & Africa Transrectal Ultrasound Market Value (USD million), by End-user, 2025 & 2034
  • Figure 54: Middle East & Africa Transrectal Ultrasound Market Value Share (%), by End-user, 2025
  • Figure 55: Middle East & Africa Transrectal Ultrasound Market Value (USD million), By Country/ Sub-region, 2025 & 2034
  • Figure 56: Middle East & Africa Transrectal Ultrasound Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 57: Global Transrectal Ultrasound Market Share (%), By Company, 2025